Executive Summary: Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition

Kalorama Information Executive Summaries
November 1, 2005
9 Pages - SKU: KLE1198635
Generic Pharmaceuticals, Global
8/12/2014 | published by: Plimsoll Publishing Ltd.
Generic Pharmaceuticals Global Analysis displays a summary of the Generic Pharmaceuticals Global market and presents a comprehensive individual analysis on the top 200 companies, including NOVARTIS AG, SIGMA PHARMACEUTICALS LIMITED and RICHTER GEDEON VEGYESZETI  |  read more...
USD 1,425
Global - Cancer Generics Market Outlook 2018
8/1/2014 | published by: RNCOS
Global Cancer Generics Market Outlook 2018 With the advent of novel and innovative technologies, industries like healthcare and pharmaceutical are scaling newer heights. One such market is the oncology market. With global cancer incidences  |  read more...
USD 1,400
Analyzing the Global Generics Industry 2014
8/1/2014 | published by: Aruvian's R'search
Analyzing the Global Generics Industry 2014 In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent  |  read more...
USD 1,750
Generic Pharma Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
Generic Pharma Deals and Alliances of 2013 The Generic Pharma Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies  |  read more...
USD 1,495
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines “PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing  |  read more...
USD 2,000
Generic Pharmaceutical Manufacturing - Industry Market Research Report - in the US
4/8/2014 | published by: IBISWorld
Generic Pharmaceutical Manufacturing in the US While this growing industry has been experiencing strong internal and external competition, the patent expirations of several brand-name drugs will create growth opportunities in the short term. Furthermore, healthcare reform  |  read more...
USD 1,020
Generic And Innovative Drugs Market In CIS Countries 2014 - Russia, Ukraine and Kazakhstan - Development Forecasts For 2014-2019
6/1/2014 | published by: PMR
Generic And Innovative Drugs Market In CIS Countries 2014 - Russia, Ukraine and Kazakhstan - Development Forecasts For 2014-2019 Compare and analyse generic and innovative drug markets in CIS countries. Report provides comprehensive market data, forecasts for  |  read more...
USD 2,800
Pharmaceuticals and Healthcare : Belgium Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Belgium Pharmaceuticals and Healthcare Report Q3 2014 Belgium continues to attract the attention of multinational firms as a European hub for clinical trials, newdrug development and niche research. However, a highly developed  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014 BMI View: The Brazilian pharmaceutical market will continue to be the most attractive to multinationalpharmaceutical companies in Latin America. Strong government support, an improving regulatory  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Estonia Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare : Estonia Pharmaceuticals and Healthcare Report Q3 2014 Estonia will continue to present a relatively limited market for pharmaceuticals despite having a positivebusiness environment. The reason for that is limited growth in pharmaceutical  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!